Focus
Commercializing Biomedical Research
- Focus issue:
- October 2012 Volume 30, No 10
The present system for commercializing biomedical research remains woefully inefficient and underpowered. This focus issue of Nature Biotechnology highlights new approaches to facilitate clinical translation of academic discovery.
Editorial
Focus on Commercializing Biomedical Research
Expanding the innovation pool - p897
doi:10.1038/nbt.2396
The biotech investment community needs to look beyond the existing pools of funding and talent to galvanize biomedical innovation.
Abstract - | Full Text - Expanding the innovation pool | PDF (122 KB) - Expanding the innovation pool
Building a business
Focus on Commercializing Biomedical Research
The changing face of corporate venturing in biotechnology - pp911 - 915
Georg von Krogh, Boris Battistini, Fotini Pachidou & Pius Baschera
doi:10.1038/nbt.2383
Corporate venture funds are playing an increasingly important role in supporting life science commercialization.
Full Text - The changing face of corporate venturing in biotechnology | PDF (466 KB) - The changing face of corporate venturing in biotechnology
Correspondence
Focus on Commercializing Biomedical Research
The Green Climate Fund as a patent pool for innovations - pp916 - 917
Menno van der Veen
doi:10.1038/nbt.2378
Full Text - The Green Climate Fund as a patent pool for innovations | PDF (94 KB) - The Green Climate Fund as a patent pool for innovations
Commentary
Focus on Commercializing Biomedical Research
Nonprofit foundations for open-source biomedical technology development - pp928 - 932
John V Frangioni
doi:10.1038/nbt.2392
For academic discoveries eschewed by traditional venture capital business models, there is now an alternative path.
Abstract - | Full Text - Nonprofit foundations for open-source biomedical technology development | PDF (268 KB) - Nonprofit foundations for open-source biomedical technology development
Focus on Commercializing Biomedical Research
Why universities should step up in venture investing - pp933 - 936
Amanda Christini
doi:10.1038/nbt.2390
University funds have a unique opportunity to bridge the gap to commercialization.
Abstract - | Full Text - Why universities should step up in venture investing | PDF (200 KB) - Why universities should step up in venture investing
Focus on Commercializing Biomedical Research
Patterns of technological innovation in biotech - pp937 - 943
Laura M McNamee & Fred D Ledley
doi:10.1038/nbt.2389
Applying theories of innovation to biotech; an analysis of the evolution of three classes of therapeutic biotechnologies.
Abstract - | Full Text - Patterns of technological innovation in biotech | PDF (988 KB) - Patterns of technological innovation in biotech | Supplementary information
Feature
Focus on Commercializing Biomedical Research
Partnering with the professor - pp944 - 952
Beth Schachter
doi:10.1038/nbt.2385
There was a time when academia viewed industry simply as a cash cow; today, it's all about sharing common goals and mutual respect for cultural differences.
Abstract - | Full Text - Partnering with the professor | PDF (527 KB) - Partnering with the professor
Patents
Focus on Commercializing Biomedical Research
Accountability in patenting of federally funded research - pp953 - 956
Arti K Rai & Bhaven N Sampat
doi:10.1038/nbt.2382
New data indicating underreporting of federal funding in academic biomedical patents highlight the pressing need for greater transparency under the Bayh-Dole Act.
Abstract - | Full Text - Accountability in patenting of federally funded research | PDF (193 KB) - Accountability in patenting of federally funded research
Perspective
Focus on Commercializing Biomedical Research
Commercializing biomedical research through securitization techniques - pp964 - 976
Jose-Maria Fernandez, Roger M Stein & Andrew W Lo
doi:10.1038/nbt.2374
The authors propose that the increasing risk of biopharma investing can be reduced through megafunds that support many biomedical programs and attract investment from large institutions such as pension funds.
Abstract - | Full Text - Commercializing biomedical research through securitization techniques | PDF (834 KB) - Commercializing biomedical research through securitization techniques | Supplementary information